EmaxHealth

Health knowledge and news provided by doctors.

Ads by Google

Breast Cancer

EmaxHealth covers the latest news about breast cancer. Breakthroughs and treatments, symptoms of signs of best cancer, discovered by the research community. Find out the latest diagnostic tools and improvements in search of breast cancer treatment.

A 'Must Read' For Breast Cancer Patients

Patent 7,309,486 issued to NexGen Biomedical discloses a better way of using Genentech's drug Herceptin against breast cancer. The patent discloses that today's practice of concurrent administration of Herceptin with conventional phase specific chemotherapy results in antagonistic action between the two classes of drugs. In later stage cancers, these protocols only increase median survival by several months.

conditions: 

Study Supports PreMD's Breast Cancer Detection Technology

PreMD data shows increased reactivity in nipple aspirate fluid from breast cancer patients. The abstract, entitled, 'Galactose oxidase Schiff's (GOS) reactivity is higher in nipple aspirate fluid from cancerous breasts than from healthy patients,' was presented by Dr. Anees B. Chagpar from the University of Louisville.

"This is a very interesting study that could influence how testing for breast cancer is performed in the future," said Brent Norton, president and chief executive officer of PreMD Inc. "With additional research, our

conditions: 

Researchers identify and repress breast cancer stem cells in mouse tissue

By manipulating highly specific gene-regulating molecules called microRNAs, scientists at Cold Spring Harbor Laboratory (CSHL) report that they have succeeded in singling out and repressing stem-like cells in mouse breast tissue - cells that are widely thought to give rise to breast cancer.

conditions: 

Anastrozole Confirmed Superior In Breast Cancer Prevention

Anastrozole is more effective than tamoxifen at preventing breast cancer recurrence for periods of at least 10 years in women with hormone-responsive cancers. In addition, the increased risk of fractures that has been seen in some patients being treated with anastrozole disappears after treatment ends.

conditions: 

Despite Early Breast Cancer Signs Test Predicts Who Could Avoid Chemotherapy

New data shows for the first time the predictive value of the 21-gene Recurrence Score (RS) assay in patients with node-positive breast cancer. The Breast Cancer Intergroup of North America trial conducted by the Southwest Oncology Group (SWOG 8814) originally showed that patients treated with 6 cycles of chemotherapy with cyclophosphamide, doxorubicin, and 5-fluorouracil followed by 5 years of tamoxifen (CAF-T) had superior disease-free survival (DFS) and overall survival (OS) compared with patients treated with tamoxifen alone.

conditions: 

Breast MRI spots other cancers, may alter treatment plan

MRI, which is not routinely administered to these patients, can find additional cancerous areas in the breast that previously evaded detection, discover cancer in the opposite breast that standard imaging tests such as mammography and ultrasound missed, or determine a tumor is actually larger than expected, the doctors say.

conditions: 

Pages